Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
subcutaneous drug delivery
Pharma
Halozyme catches M&A wave to snap up Surf Bio
With IP protections extending into the mid-2040s, both Elektrofi & Surf could provide long-term, durable royalty revenue streams, Halozyme's CEO said.
Angus Liu
Jan 28, 2026 2:06pm
GSK licenses Alteogen enzyme in bid to develop subQ Jemperli
Jan 20, 2026 2:26pm
Roche's bispecific Lunsumio goes subcutaneous
Dec 22, 2025 10:15am
FDA approves J&J's new challenge to Tagrisso
Dec 18, 2025 10:40am
Argenx cans Vyvgart trials in thyroid eye disease over futility
Dec 15, 2025 10:00am
Merck's Keytruda SC launch in Germany faces legal hurdle
Dec 5, 2025 9:30am
